乙型/丙型肝炎肝硬化患者外周血清鞘脂表达谱特征分析

王扬; 铁偲; 刘霜; 陈煜; 段钟平; 郑素军; 张金兰

doi:10.3969/j.issn.1001-5256.2020.08.012

乙型/丙型肝炎肝硬化患者外周血清鞘脂表达谱特征分析

DOI: 10.3969/j.issn.1001-5256.2020.08.012

1. 首都医科大学附属北京佑安医院疑难肝病与人工肝中心
2. 协和医科大学中国医学科学院药物研究所

基金项目:

国家科技重大专项“艾滋病和病毒性肝炎等重大传染病防治”(2017ZX10302201-004,2017ZX10202203-006,2017ZX10201201,2017ZX10203201-005)；

详细信息

中图分类号: R575.2;R512.6
计量
- 文章访问数: 1269
- HTML全文浏览量: 32
- PDF下载量: 152
- 被引次数: 0
出版历程
- 出版日期: 2020-08-20

Expression profiles of sphingolipids in peripheral serum in patients with hepatitis B/C cirrhosis

Difficult & Complicated Liver Diseases and Artificial Liver Center, Beijing YouAn Hospital, Capital Medical University

Research funding:

摘要

摘要:
目的探索乙型/丙型肝炎肝硬化与非病毒性肝硬化患者外周血清鞘脂的不同表达谱特征。方法选取2014年7月-2015年5月首都医科大学附属北京佑安医院疑难肝病及人工肝中心收治的104例肝硬化患者为研究对象，最终纳入97例肝硬化患者，其中包括66例（68.04%）乙型/丙型肝炎肝硬化及31例（31.96%）非病毒性肝硬化患者。采用高效液相色谱－质谱分析法检测患者外周血清中57种鞘脂的表达水平，计量资料两组间比较采用t检验或Mann-Whitney U检验。计数资料两组间比较采用χ2检验。单因素分析结果中有意义的变量纳入logistic多因素回归分析。结果两组患者年龄、男性比例、TBil、DBil及GGT等临床指标之间差异均无统计学意义（P值均＞0.05）。检测57种血清鞘脂表达中，Cer(d18∶1/12∶0)、HexCer (d18∶1/14∶1)和dhCer(d18∶0/24∶1)-1-P在病毒性肝炎肝硬化组的表达水平分别为168.61（168.54~168.88）pmol/0.1 ml、213.93（211.15~218.92）pmol/0.1 ml、60.07(59.40~61.23) pmol/0.1ml，均高于非病毒性肝硬化组［168.53（168.48~168.63）pmol/0.1ml、212.26（209.90~214.64）pmol/0.1 ml、59.42(59.28~59.87) pmol/0.1 ml］，两组间差异均有统计学意义（Z值分别为-2.54、-2.03、-2.32，P值均＜0.05）。logistics回归分析结果表明，dhCer(d18∶0/24∶1)-1-P高表达与乙型/丙型肝炎肝硬化独立相关(比值比=1.11，95%可信区间1.004~1.225, P=0042)。病毒性肝炎肝硬化患者亚组分析结果表明，Cer(d18∶1/12∶0)、HexCer (d18∶1/14∶1)和dhCer(d18∶0/24∶1)-1-P在乙型肝炎肝硬化和丙型肝炎肝硬化患者之间的表达水平差异均无统计学意义（Z值分别为-0.563、-0.610、-0.579，P值均＞0.05）。结论外周血清鞘脂dhCer(d18∶0/24∶1)-1-P与乙型/丙型肝炎肝硬化密切相关，可能有助于从鞘脂角度深入理解病毒性肝硬化的疾病特征。
- 肝硬化 /
- 鞘脂类 /
- 色谱法,高压液相
Abstract:
ObjectiveTo investigate the expression profiles of sphingolipids in peripheral serum in patients with hepatitis B/C cirrhosis and those with non-viral hepatitis-related cirrhosis. MethodsA total of 104 patients with liver cirrhosis who were admitted to Difficult & Complicated Liver Diseases and Artificial Liver Center, Beijing YouAn Hospital, Capital Medical University, from July 2014 to May 2015 were enrolled as subjects, and finally 97 patients with liver cirrhosis were enrolled, among whom there were 66 patients (68.04%) with hepatitis B/C cirrhosis and 31 patients (31.96%) with non-viral hepatitis-related cirrhosis. High-performance liquid chromatography-mass spectrometry was used to measure the expression of 57 sphingolipids in peripheral serum. The t-test or the Mann-Whitney U test was used for comparison of continuous data between two groups, and the chi-square test was used for comparison of categorical data between two groups. The variables with statistical significance in the univariate analysis were included in the multivariate analysis. ResultsThere were no significant differences between the two groups in age, proportion of male patients, total bilirubin, direct bilirubin, and gamma-glutamyl transpeptidase (all P＞0.05). As for the 57 sphingolipids in peripheral serum, compared with the non-viral hepatitis-related cirrhosis group, the viral hepatitis-related cirrhosis group had significantly higher expression of Cer(d18∶1/12∶0) ［168.61 (16854-168.88) pmol/0.1 ml vs 168.53 (168.48-168.63) pmol/0.1 ml, Z=-2.54, P＜0.05］, HexCer (d18∶1/14∶1) ［213.93 (211.15-218.92) pmol/0.1 ml vs 212.26 (209.90-214.64) pmol/0.1 ml, Z=-2.03, P＜0.05］, and dhCer(d18∶0/24∶1)-1-P ［60.07 (59.40-61.23) pmol/0.1 ml vs 59.42 (59.28-59.87) pmol/0.1 ml, Z=-2.32, P＜0.05］. The logistic regression analysis revealed that high expression of dhCer(d18∶0/24∶1)-1-P was independently associated with hepatitis B/C cirrhosis (odds ratio=111, 95% confidence interval: 1.004-1.225, P=0.042). The subgroup analysis of the patients with viral hepatitis-associated cirrhosis showed that there were no significant differences between the patients with hepatitis B cirrhosis and those with hepatitis C cirrhosis in the expression of Cer(d18∶1/12∶0), HexCer (d18∶1/14∶1), and dhCer(d18∶0/24∶1)-1-P (Z=-0.563, -0.610, and -0.579, all P＞0.05). ConclusionThe sphingolipid dhCer (d18∶0/24∶1)-1-P in peripheral serum is closely associated with hepatitis B/C cirrhosis and may help to understand the features of viral hepatitis-related cirrhosis from the perspective of sphingolipids.
- liver cirrhosis /
- sphingolipids /
- chromatography,high pressure liquid

HTML全文

参考文献(17)

[1]SINN DH,LEE J,GOO J,et al.Hepatocellular carcinoma risk in chronic hepatitis B virus-infected compensated cirrhosis patients with low viral load[J].Hepatology,2015,62(3)∶694-701．

[2]MARM,FERNNDEZ-CHECA JC.Sphingolipid signalling and liver diseases[J].Liver Int,2007,27(4):440-450．

[3]FERNANDEZ A,MATIAS N,FUCHO R,et al.ASMase is required for chronic alcohol induced hepatic endoplasmic reticulum stress and mitochondrial cholesterol loading[J].J Hepatol,2013,59(4):805-813．

[4]TONG M,LONGATO L,RAMIREZ T,et al.Therapeutic reversal of chronic alcohol-related steatohepatitis with the ceramide inhibitor myriocin[J].Int J Exp Pathol,2014,95(1):49-63．

[5]PRALHADA RAO R,VAIDYANATHAN N,RENGASAMY M,et al.Sphingolipid metabolic pathway:An overview of major roles played in human diseases[J].J Lipids,2013,2013:178910．

[6]GRAMMATIKOS G,SCHOELL N,FERREIRS N,et al.Serum sphingolipidomic analyses reveal an upregulation of C16-ceramide and sphingosine-1-phosphate in hepatocellular carcinoma[J].Oncotarget,2016,7(14):18095-18105．

[7]WU T,ZHENG X,YANG M,et al.Serum lipid alterations identified in chronic hepatitis B,hepatitis B virus-associated cirrhosis and carcinoma patients[J].Sci Rep,2017,7:42710．

[8]DJIAMBOU-NGANJEU H.Hepatic encephalopathy in liver cirrhosis[J].J Transl Int Med,2017,5(1):64-67．

[9]NOSRATABADI R,ALAVIAN SM,ZARE-BIDAKI M,et al.Innate immunity related pathogen recognition receptors and chronic hepatitis B infection[J].Mol Immunol,2017,90:64-73．

[10]XU Y,ZHONG J.Innate immunity against hepatitis C virus[J].Curr Opin Immunol,2016,42:98-104．

[11]LI K,LI NL,WEI D,et al.Activation of chemokine and inflammatory cytokine response in hepatitis C virus-infected hepatocytes depends on Toll-like receptor 3 sensing of hepatitis Cvirus double-stranded RNA intermediates[J].Hepatology,2012,55(3):666-675．

[12]QU F,ZHENG SJ,LIU S,et al.Serum sphingolipids reflect the severity of chronic HBV infection and predict the mortality of HBV-acute-on-chronic liver failure[J].PLo S One,2014,9(8):e104988．

[13]ZHANG JY,QU F,LI JF,et al.Up-regulation of plasma hexosylceramide (d18∶1/18∶1) contributes to genotype 2 virus replication in chronic hepatitis C:A 20-year cohort study[J].Medicine (Baltimore),2016,95(23):e3773．

[14]CINGOLANI F,SIMBARI F,ABAD JL,et al.Jaspine B induces nonapoptotic cell death in gastric cancer cells independently of its inhibition of ceramide synthase[J].J Lipid Res,2017,58(8):1500-1513．

[15]OLSEN I,NICHOLS FC.Are sphingolipids and serine dipeptide lipids underestimated virulence factors of porphyromonas gingivalis?[J].Infect Immun,2018,86(7):e00035-18．

[16]NICHOLS FC,HOUSLEY WJ,O’CONOR CA,et al.Unique lipids from a common human bacterium represent a new class of Toll-like receptor 2 ligands capable of enhancing autoimmunity[J].Am J Pathol,2009,175(6):2430-2438．

[17]NICHOLS FC,YAO X,BAJRAMI B,et al.Phosphorylated dihydroceramides from common human bacteria are recovered in human tissues[J].PLo S One,2011,6(2):e16771.

施引文献

资源附件(0)

访问统计